LALPATHLAB — Dr. Lal PathLabs Share News
0.000.00%
Last trade - 00:00- IN₹311.00bn
- IN₹299.44bn
- IN₹27.63bn
India's Metropolis Healthcare hits near 2-yr high on revenue, margin jump
Brief: Dr. Lal Pathlabs Gets Assessment Order
India's Dr. Lal PathLabs surges on Kotak double-upgrade to "buy"
India's Dr. Lal PathLabs could beat margin guidance, boost investments, UBS says
Brief: Dr. Lal Pathlabs Gets Tax Demand Of 26.3 Million Rupees
Brief: Dr. Lal Pathlabs Approved The Re-Designation Of Shankha Banerjee By Appointing Him As CEO With Effect From May 21, 2024.
India's Dr. Lal PathLabs slips after CEO resigns
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests
Brief: Dr. Lal Pathlabs Dec-Quarter Consol Net Profit 813 Million Rupees
India's diagnostic firms rise amid uptick in new COVID cases
India's Dr. Lal Pathlabs up on Q2 profit jump
Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit Rises
India's Dr. Lal PathLabs beats Q1 profit view on strong testing demand
India's Dr. Lal Pathlabs hits near 8-mnth high on Q1 profit rise
Brief: India's Dr. Lal Pathlabs Q1 Consol Net Profit Beats Estimates
India's Dr. Lal PathLabs rises; brokerage reiterates "buy"
Kotak cautions further pressure on margins for India's Dr. Lal PathLabs
India's Dr. Lal PathLabs reports decline in Q4 profit
India's Dr. Lal PathLabs falls on Q4 profit slide